NORTION BPH

Technical Principle

By placing electrodes around the hypertrophic gland at the urethra and bladder neck, and delivering pulsed electric field ablation, the ablated cells undergo apoptosis and necrosis within 7-14 days. These cells are subsequently phagocytosed, thereby relieving compression of the urethra and bladder neck, which ultimately improves voiding dysfunction.

Applications



Product Advantages

Significantly improves lower urinary tract symptoms

Demonstrated a mean maximum urinary flow rate (Qmax) improvement of 8.41 mL/s, International Prostate Symptom Score (IPSS) reduction of 13.04 points, and 20.76% prostate volume shrinkage.;

Preserves continence and sexual function

The tissue-selective/non-thermal ablation spares continence-related nerves, sexual nerves, and muscle fiber structures, thereby enabling complete preservation of urinary continence and sexual function.

The  ablation therapy that does not damage the urethral mucosa

The transperineal approach bypasses the urethra without causing damage, thus preserving urethral mucosal integrity.

Ultra-minimally invasive procedure

Features a streamlined workflow with a short learning curve for clinicians, causes remarkably minimal tissue trauma (only a few 1mm puncture sites in the perineal region), and results in no significant bleeding.

Significantly reduced hospitalization duration

Day surgery procedure with hospitalization limited to ≤24 hours.

Product Configuration

No.ComponentComponent Model Number
1Rack-Mounted Main Control Unit (with Integrated Display)IRE-BPH-01-A
2Bottom Rack Space for Main Control UnitIRE-BPH-01-B
3FootswitchHRF-M5Y/A
4Inter-cabinet signal cablePT-CNT-36A
5Inter-cabinet power cable/
6AC power cable/